Anaheim Hills, CA, United States of America

Oliver Ulibas

This inventor holds 2 USPTO granted patents. Top assignee: Vycon, Inc.. Active years: 2015.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Oliver Ulibas: Innovator in Power Supply Systems

Introduction

Oliver Ulibas is a notable inventor based in Anaheim Hills, CA (US). He has made significant contributions to the field of power supply systems, holding 2 patents that showcase his innovative approach to energy solutions.

Latest Patents

Ulibas's latest patents include a flywheel and battery-based power supply system. This system features a flywheel that is electrically coupled to a DC bus, allowing for the efficient supply of electrical power between a power grid and a load. The flywheel is designed to rotate with a rotor of a motor/generator, enhancing the overall efficiency of the power supply. Additionally, a battery system is integrated into the design, working concurrently with the flywheel system to provide a reliable energy source.

Career Highlights

Throughout his career, Ulibas has demonstrated a commitment to advancing technology in the energy sector. His work at Vycon, Inc. has positioned him as a key player in the development of innovative power solutions. His expertise in integrating flywheel technology with battery systems has paved the way for more sustainable energy practices.

Collaborations

Ulibas has collaborated with talented individuals such as Frank DeLattre and Octavio Solis. These partnerships have fostered a creative environment that encourages the development of cutting-edge technologies in power supply systems.

Conclusion

Oliver Ulibas is a distinguished inventor whose work in power supply systems reflects his dedication to innovation and sustainability. His contributions continue to influence the energy sector positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…